Print

Ocular Therapeutix, Inc. Wins FDA Panel Date for ReSure Sealant  
8/5/2013 7:41:21 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

An FDA advisory panel will review the ReSure sealant made by Ocular Therapeutix, a hydrogel designed to seal incisions in the eye's cornea. An FDA advisory panel is slated to convene Sept. 19 to review the pre-market approval application for Ocular Therapeutix Inc.'s ReSure sealant. The FDA's Ophthalmic Devices Panel will review the PMA for the ReSure product, a hydrogel designed to seal incisions to the cornea made during cataract or intraocular lens placement surgery.

Help employers find you! Check out all the jobs and post your resume.

//-->